Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2021-02-24 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
UK-RTC statement on AbC-19TM rapid antibody test
Regulatory Filings Classification · 1% confidence The document is a press release issued via the RNS Reach service, which is a non-regulatory news distribution platform. It provides an update on clinical study data regarding the AbC-19 rapid antibody test. Since it does not fit into specific categories like financial reports, board changes, or dividend announcements, and is a general corporate announcement distributed via RNS, it falls under the Regulatory Filings (RNS) category.
2021-02-24 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an RNS announcement detailing a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically Angela Robertson, who exercised share options and subsequently sold the shares. It includes the required regulatory disclosure table under Article 19(1) of the Market Abuse Regulation. While it mentions total voting rights, the primary purpose is to report a director's dealing/transaction in shares. Therefore, it falls under the 'Director's Dealing' category.
2021-02-19 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an RNS announcement detailing a transaction by a person discharging managerial responsibilities (PDMR), specifically a Non-Executive Director (William Rhodes) exercising share options and subsequently selling those shares. It also includes the required disclosure table under Article 19(1) of the Market Abuse Regulation. While it mentions total voting rights, the primary purpose is the disclosure of a director's share dealing. Therefore, it is classified as a Director's Dealing (DIRS).
2021-02-18 English
AbC-19TM rapid antibody test performance data
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service regarding performance data for a medical product (AbC-19TM rapid antibody test). It does not constitute a formal financial report, governance filing, or regulatory disclosure, but rather a corporate announcement about product research. As it does not fit into specific categories like 10-K, IR, or M&A, and is a general corporate announcement, it falls under the RNS (Regulatory Filings) category as the fallback for miscellaneous announcements.
2021-02-16 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official announcement from Omega Diagnostics Group PLC regarding share transactions by directors and PDMRs (Persons Discharging Managerial Responsibilities). It includes detailed tables of share options exercised and subsequent sales, as well as the required regulatory notifications under Article 19(1) of the EU Market Abuse Regulation. This falls squarely under the definition of 'Director's Dealing' (DIRS).
2021-02-15 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is a short notification from the London Stock Exchange's RNS (Regulatory News Service) regarding a 'Price Monitoring Extension' for a specific security. It does not contain financial statements, management reports, or corporate governance disclosures. As it is a standard regulatory notification regarding trading mechanics that does not fit into the specific categories like M&A, dividends, or share issues, it falls under the general regulatory filing category.
2021-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.